College of Nursing Dean Greer Glazer Joins Board of The Sullivan Alliance
Greer Glazer, PhD, dean of the University of Cincinnati (UC) College of Nursing, has joined the Board of Directors of The Sullivan Alliance to Transform the Health Professions.
"As we look forward to the future, we recognize the need for expanded interprofessional training and care delivery to address the health demands of our nation, said The Sullivan Alliance Chairman and CEO Louis Sullivan, MD. "As a part of our board of directors, Dr. Glazers strong leadership skills and deep engagement in diversity efforts will be a tremendous asset to our efforts to increase diversity across the health workforce.
Glazer has been involved in efforts to diversify the nursing workforce since 2004 with significant HRSA foundation and health care funding for pipeline institutional projects. Her professional organization involvement includes AACN Board of Directors, the Coalition Urban Serving Universities Urban Health Initiative Committee, and past chairperson of the American Association of Colleges of Nursing Executive Development Series.
"I am honored and humbled to serve on such an important board under the leadership of an icon, Dr. Louis Sullivan, said Glazer. "I hope that in some small way I can contribute to the diversification of the health care workforce in the United States which is sorely needed. Glazer is UCs seventh dean of nursing and 14th senior leader of the college, which was led for its first 51 years by a superintendent or director.
Tags
Related Stories
Selecting noninvasive tests for liver disease diagnosis, monitoring
September 3, 2026
Noninvasive tests have emerged as valuable alternatives for diagnosing, staging and monitoring MASLD and MASH, according to a recent MedCentral report.
Why can it get so hot at times?
September 3, 2026
Cincinnati is experiencing more days of extreme heat this summer than in previous decades, due in large part to warmer global temperatures. But explanations for these higher temperatures also relate to regional factors, including the city's location in a river valley and large proportion of built environment.
Cancer Center plays key role in lab research, clinical trials for new pancreatic cancer drug
September 1, 2026
WLWT and WCPO highlighted the contributions of University of Cincinnati Cancer Center researchers that helped lead to the recent FDA approval of daraxonrasib, a new treatment for pancreatic cancer.